Avanos Medical AVNS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$72.9M+81.4% | -$392.1M— | —— | $50.5M+702% | ||
| $38.9M-14.5% | $45.5M-1.3% | $46.1M-3.4% | $47.7M+24.5% | ||
| $12.6M-8.7% | $13.8M-12.7% | $15.8M-0.6% | $15.9M+20.5% | ||
| -$7.8M+78.3% | -$35.9M-343% | -$8.1M-1,250% | -$600K-116% | ||
| $0— | $0+100% | -$70.8M— | $0— | ||
| $800K+14.3% | $700K0.0% | $700K-73.1% | $2.6M— | ||
| -$33.9M— | —— | —— | —— | ||
| -$200K+99.5% | -$39M-730% | -$4.7M— | —— | ||
| —— | —— | —— | $35.4M— | ||
| —— | —— | —— | —— | ||
| -$1.4M+90.6% | -$14.9M-176% | $19.6M— | —— | ||
| -$10.4M+73.6% | -$39.4M-75.9% | -$22.4M— | $0— | ||
| $74.7M-25.8% | $100.7M+211% | $32.4M-64.4% | $90.9M+4.1% | ||
| $31.6M+77.5% | $17.8M0.0% | $17.8M-7.8% | $19.3M-8.1% | ||
| $23.4M— | $0-100% | $49.6M— | —— | ||
| $23.3M-11.1% | $26.2M-3.7% | $27.2M-8.4% | $29.7M-2.9% | ||
| -$60.6M-120% | -$27.5M-227% | $21.6M+116% | -$135.4M-545% | ||
| $3.3M-74.2% | $12.8M-33.0% | $19.1M-58.0% | $45.5M+296% | ||
| —— | $45M— | —— | $170M— | ||
| —— | —— | —— | $1.7M— | ||
| -$37M+24.6% | -$49.1M+47.9% | -$94.2M— | —— | ||
| $5.3M+229% | -$4.1M— | —— | —— | ||
| —— | —— | —— | —— | ||
| $6.5M-43.5% | $11.5M-21.8% | $14.7M+81.5% | $8.1M+170% | ||
| $14.1M— | —— | —— | —— | ||
| $12.6M-8.7% | $13.8M-12.7% | $15.8M-0.6% | $15.9M+20.5% | ||
| $19.7M-3.0% | $20.3M+5.7% | $19.2M+3.8% | $18.5M+8.8% | ||
| —— | —— | —— | —— | ||
| $0— | $0+100% | -$70.8M— | $0— | ||
| —— | $6.9M— | —— | —— | ||
| $0— | —— | —— | —— | ||
| —— | —— | —— | $35.4M— | ||
| -$1.4M+90.6% | -$14.9M-176% | $19.6M— | —— | ||
| $9.4M+67.9% | $5.6M+3.7% | $5.4M-37.2% | $8.6M— | ||
| $0— | $0— | $0— | $0-100% | ||
| $800K+14.3% | $700K0.0% | $700K-73.1% | $2.6M— | ||
| —— | —— | —— | —— | ||
| $0-100% | $2.1M— | $0— | $0— | ||
| $9.4M+9.3% | $8.6M+83.0% | $4.7M-96.3% | $126.6M— | ||
| $347.3M+13.3% | $306.5M+4.4% | $293.6M-5.6% | $310.9M+8.0% | ||
| $14.5M-23.3% | $18.9M+87.1% | $10.1M+12.2% | $9M+160% | ||
| -$1.57+81.6% | -$8.53— | —— | $1.09+679% | ||
| -$1.57+81.6% | -$8.53— | —— | $1.06+715% | ||
| —— | —— | —— | —— | ||
| $2M— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $2.6M+165% | -$4M— | —— | -$1.5M-66.7% | ||
| $353.9M-7.2% | $381.3M+0.4% | $379.7M-7.7% | $411.3M+37.3% | ||
| -$67.4M+83.3% | -$403.3M— | —— | $39.3M+193% | ||
| $7.8M-36.1% | $12.2M-18.7% | $15M+50.0% | $10M— | ||
| $3.2M-37.3% | $5.1M+75.9% | $2.9M+142% | $1.2M+500% | ||
| -$64.1M+83.8% | -$396.2M-9,533% | $4.2M-91.3% | $48.1M+224% | ||
| -$200K— | $0— | $0— | $0— | ||
| $400K-89.7% | $3.9M+129% | -$13.3M-316% | -$3.2M— | ||
| $701.2M+1.9% | $687.8M+2.2% | $673.3M-6.8% | $722.2M+23.0% | ||
| $315.6M-0.9% | $318.5M-4.9% | $335M+1.4% | $330.3M+15.8% | ||
| $0— | $0— | $0— | $0-100% | ||
| 700K-53.3% | 1.5M— | 0-100% | 1.6M+60.0% | ||
| 185.8M+0.1% | 185.6M-0.6% | 186.8M-1.5% | 189.7M-1.9% | ||
| 185.1M+0.5% | 184.1M-1.4% | 186.8M-0.7% | 188.1M-2.2% | ||
| $4.1M— | —— | —— | —— | ||
| $14.1M— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$14.1M-327% | -$3.3M+86.0% | -$23.6M-914% | $2.9M-93.6% | ||
| $47.3M-42.9% | $82.9M+468% | $14.6M-79.6% | $71.6M+8.0% | ||
| $47.3M-42.9% | $82.9M+468% | $14.6M-79.6% | $71.6M+8.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Avanos Medical generate?
- Avanos Medical (AVNS) generated $36.7M in operating cash flow over the trailing twelve months.
- What is Avanos Medical's free cash flow?
- After $29.2M of capital expenditures, Avanos Medical's free cash flow was $11.7M over the trailing twelve months, down 89.7% year over year.
- Where does Avanos Medical's cash flow data come from?
- Every line is extracted from Avanos Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
